Cargando…

Redefining the Standard for Atrial Fibrillation: A Patient-centric Report

A roundtable discussion with three European clinical experts in AF and one expert patient diagnosed and treated for AF was conducted in London in October 2019. The panel discussed the implications of AF for patients, current patient pathways, what treatment outcomes were relevant for patients and ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lundqvist, Carina Blomström, Pürerfellner, Helmut, White, Alex, Schilling, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2021
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034477/ https://www.ncbi.nlm.nih.gov/pubmed/33859732 http://dx.doi.org/10.15420/ecr.2021.16.s1

Ejemplares similares

Left atrial function after epicardial pulmonary vein isolation in patients with atrial fibrillation
por: Bagge, Louise, et al.
Publicado: (2017)

Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis
por: Blomstrom-Lundqvist, Carina, et al.
Publicado: (2021)

Catheter ablation of symptomatic atrial fibrillation: Sex, ethnicity, and socioeconomic disparities
por: Björkenheim, Anna, et al.
Publicado: (2022)

Atrial Fibrillation Ablation in Heart Failure Patients
por: Derndorfer, Michael, et al.
Publicado: (2021)

Redefining Success for VAP: 360-Degree Approach
por: Nicolau, David P., et al.
Publicado: (2009)

Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study
por: Blomström‐Lundqvist, Carina, et al.
Publicado: (2020)

Recent-onset atrial fibrillation: a study exploring the elements of Virchow’s triad after cardioversion
por: Arvanitis, Panagiotis, et al.
Publicado: (2021)

Effect of dronedarone vs. placebo on atrial fibrillation progression: a post hoc analysis from ATHENA trial
por: Blomström-Lundqvist, Carina, et al.
Publicado: (2023)

Atrial fibrillation burden, episode duration and frequency in relation to quality of life in patients with implantable cardiac monitor
por: Jansson, Victoria, et al.
Publicado: (2021)

Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey
por: Reiffel, James A, et al.
Publicado: (2023)

Dronedarone versus sotalol in patients with atrial fibrillation: A systematic literature review and network meta‐analysis
por: Singh, Jagmeet P., et al.
Publicado: (2023)

User, Usage and Usability: Redefining Human Centric Cyber Security
por: Grobler, Marthie, et al.
Publicado: (2021)

Atrial Fibrillation and Fibrosis: Beyond the Cardiomyocyte Centric View
por: Miragoli, Michele, et al.
Publicado: (2015)

Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
por: Lip, Gregory Y H, et al.
Publicado: (2023)

Progress in atrial fibrillation ablation during 25 years of Europace journal
por: Boersma, Lucas, et al.
Publicado: (2023)

Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor
por: Potpara, Tatjana S., et al.
Publicado: (2016)

Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation
por: Giugliano, Robert P
Publicado: (2022)

Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review
por: Calvert, Peter, et al.
Publicado: (2023)

Antibiotic-Eluting Envelopes for the Prevention of Cardiac Implantable Electronic Device Infections: Rationale, Efficacy, and Cost-Effectiveness
por: Traykov, Vassil, et al.
Publicado: (2022)

The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases
por: Verhaert, Dominique V M, et al.
Publicado: (2021)

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with advanced chronic kidney and liver diseases
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Repolarization abnormalities unmasked with a 252‐lead BSM system in patients with ARVC and healthy gene carriers
por: Kommata, Varvara, et al.
Publicado: (2022)

AFA-Recur: an ESC EORP AFA-LT registry machine-learning web calculator predicting atrial fibrillation recurrence after ablation
por: Saglietto, Andrea, et al.
Publicado: (2022)

The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration
por: Ogrinc, G, et al.
Publicado: (2008)

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
por: Geng, Meng, et al.
Publicado: (2020)

Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
por: Farinha, José Maria, et al.
Publicado: (2022)

Radiomic Phenotype of Periatrial Adipose Tissue in the Prognosis of Late Postablation Recurrence of Idiopathic Atrial Fibrillation
por: Ilyushenkova, J.N., et al.
Publicado: (2023)

Epicardial conduction abnormalities in patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and mutation positive healthy family members – A study using electrocardiographic imaging
por: Kommata, Varvara, et al.
Publicado: (2023)

Using machine learning to identify local cellular properties that support re-entrant activation in patient-specific models of atrial fibrillation
por: Corrado, Cesare, et al.
Publicado: (2021)

From peer-based to peer-led: redefining the role of peers across the hepatitis C care pathway: HepCare Europe
por: Surey, Julian, et al.
Publicado: (2019)

Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation
por: Pürerfellner, H, et al.
Publicado: (2006)

Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
por: White, Michael, et al.
Publicado: (2011)

Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis
por: Caso, Valeria, et al.
Publicado: (2023)

Cardiac device infection: removing barriers to timely and adequate treatment
por: Atar, Dan, et al.
Publicado: (2023)

Atrial fibrillation fundamentals: from physiopathology to transcatheter ablation
por: Gaita, Fiorenzo, et al.
Publicado: (2023)

Both beat-to-beat changes in RR-interval and left ventricular filling time determine ventricular function during atrial fibrillation
por: Lyon, Aurore, et al.
Publicado: (2021)

Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors
por: Pürerfellner, Helmut, et al.
Publicado: (2018)

Abstract 111: Redefining the Role of Resection Weight Prediction in Breast Reduction Surgery
por: Boukovalas, Stefanos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p4a65gt3js9rlbugh6rnkrecol